A detailed history of Foresight Group LTD Liability Partnership transactions in Novo Nordisk A S stock. As of the latest transaction made, Foresight Group LTD Liability Partnership holds 124,919 shares of NVO stock, worth $7.11 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
124,919
Holding current value
$7.11 Million
% of portfolio
1.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$58.08 - $81.05 $7.26 Million - $10.1 Million
124,919 New
124,919 $8.64 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $129B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Foresight Group LTD Liability Partnership Portfolio

Follow Foresight Group LTD Liability Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresight Group LTD Liability Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Foresight Group LTD Liability Partnership with notifications on news.